Generics Industry News Search
 |
|
|
|
|
|
|
October 2011 News Archive |
|
|
| |
|
The Medicines Company announced that it has settled lawsuits with Teva for generic versions of Angiomax...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Abbott Laboratories is waging a legal battle in three courts on two continents against North Shore neighbor Hospira over a generic version of Zemplar...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
AstraZeneca announced it has entered into a settlement agreement in its SEROQUEL patent infringement litigation against Accord Healthcare and Intas Phamaceuticals...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Perrigo Company announced that it received tentative approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Clobetasol propionate emulsion foam, 0.05%. Perrigo believes it is first-to-file on this product...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pfizer sues Merck to block a new Lipitor and Zetia combination pill...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Navamedic ASA, the Norwegian pharmaceutical products company, today announced the successful launch of its two first generic pharmaceutical products. The launch is an important milestone in the development of Navamedics new generics business area....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Hisamitsu Pharmaceutical Co.'s Noven Pharmaceuticals unit sued Watson Pharmaceuticals Inc. to prevent it from selling a generic version of Daytrana, a skin patch for children with attention deficit disorder...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lannett announced that it has begun shipping three generic drugs that recently were approved by the Food and Drug Administration...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market Risedronate Sodium delayed-release tablets, 35 mg. Watson's Risedronate Sodium delayed-release tablets are a generic version of Warner Chilcott, LLC's Atelvia delayed-release tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Anadys Pharmaceuticals today announced that it has entered into a definitive merger agreement to be acquired by Roche. Under the terms of the merger agreement, Roche will commence an all cash tender offer for all outstanding shares of common stock of Anadys at USD 3.70 per share...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Perrigo company announced that it has filed with the U.S. Food and Drug Administration an Abbreviated New Drug Application for Olopatadine hydrochloride nasal spray and that it has notified Alcon Laboratories, the owner of the New Drug Application. The ANDA filing involved contributions from Perrigo's partner, Impax Laboratories, who will share costs and benefits of this project...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced that it, along with Famy Care, has entered into a settlement agreement with Warner Chilcott resolving litigation related to Femcon Fe chewable tablets, known generically as Norethindrone and Ethinyl Estradiol tablets (chewable), 0.4 mg/0.035 mg and Ferrous Fumarate tablets (chewable), 75 mg (28-day regimen). This medication is an oral contraceptive...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Impax Laboratories Inc. said it settled patent litigation with Abbott Laboratories and its Fournier Laboratories Ireland Ltd. unit, permitting Impax to sell a generic version of the cholesterol drug TriLipix as early as 2013...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva and Dr Reddy announce the commercial launch of Olanzapine tablets, the generic version of Eli Lilly's Zyprexa...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan said that one of its subsidiaries had received final approval for its generic version of Morphine sulfate extended-release tablets, the generic version of Purdue Pharma's MS Contin opioid pain reliever, and will begin marketing the drug immediately...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Innopharma announced today FDA approval of its Abbreviated New Drug Application for Olanzapine injection (the generic equivalent of Zyprexa injection)...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
A subsidiary of Sun Pharmaceutical Industries has received US Food and Drugs Administration approval for its abbreviated new drug application to market a generic version of Valeant International's Cardizem CD, Diltiazem Hcl extended release capsules...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lupin believes that it is one of the first applicants to file an ANDA for LoSeasonique tablets and will be entitled to 180 days of marketing exclusivity...
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
